Cascadian Therapeutics Inc (USA) Stock

Stocks

04/01/18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
02/01/18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
13/12/17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
08/12/17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
09/11/17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
WUXI APPTEC CO., LTD.	-0.21%	-4.43%	+44.40%	+74.13%	66.22B
ARGENX SE	+0.82%	+5.41%	+8.05%	+73.53%	55.2B
LONZA GROUP AG	-0.22%	+6.53%	+11.68%	+87.32%	52.79B
IQVIA HOLDINGS INC.	+3.28%	+5.58%	+26.51%	+50.05%	45.53B
BEONE MEDICINES AG	+0.51%	+9.95%	+22.40%	+133.92%	43.94B
REVOLUTION MEDICINES, INC.	-1.15%	+0.39%	+263.21%	+594.60%	41.64B
CELLTRION, INC.	+0.10%	+9.90%	+16.11%	+59.33%	34B
WUXI BIOLOGICS (CAYMAN) INC.	-7.65%	-6.21%	+27.36%	-1.15%	25.84B
GENMAB A/S	+0.69%	+5.60%	+36.60%	+26.94%	23.51B
Average	-0.38%	+4.07%	+50.70%	+122.07%	43.19B
Weighted average by Cap.	-0.09%	+3.72%	+49.57%	+126.38%

Employees

Sector